Zeria Pharmaceutical Co., Ltd.
Notice Regarding Cancellation of Treasury Stock
Zeria Pharmaceutical Co., Ltd. announced plans to cancel 1,000,000 shares of common stock (1.96% of the total outstanding shares) on February 25, 2026.
Key Figures
- Total number of shares to be canceled: 1,000,000 shares (1.96% of total outstanding shares)
- Scheduled cancellation date: 2026-02-25
- Total outstanding shares after cancellation: 50,119,190 shares
AI要約
Overview of Capital Policy
At the Board of Directors meeting held on February 5, 2026, Zeria Pharmaceutical Co., Ltd. resolved to cancel treasury stock pursuant to Article 178 of the Companies Act. The shares to be canceled consist of 1,000,000 shares of common stock, representing approximately 1.96% of the total outstanding shares before the cancellation. The scheduled cancellation date is February 25, 2026, after which the total outstanding shares will be 50,119,190.
Impact on Shareholders
This treasury stock cancellation will reduce the total number of outstanding shares, which is expected to enhance the value per share. The number of canceled shares represents about 1.96% of the total outstanding shares, aiming to eliminate dilution and improve capital efficiency. There is no information provided regarding the use of funds or specific financial impacts.
